Members of the vascular endothelial growth factor (VEGF) family are among the most
powerful modulators of vascular biology. They regulate vasculogenesis, angiogenesis, and …

The discovery of vascular endothelial growth factors (VEGFs) and their receptors has
considerably improved the understanding of the development and function of endothelial …

There is widespread interest in the use of the angiogenic cytokine, vascular endothelial
growth factor (VEGF), for the treatment of cardiovascular disease. The main paradigm for …

Therapeutic angiogenesis is a novel approach to the treatment of coronary and peripheral
vascular disease not amenable to standard revascularization techniques. Vascular …

Vascular endothelial growth factor (VEGF) is best known as a cytokine essential for
embryonic vasculogenesis and for the angiogenesis associated with various pathologies …

Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various
ischemic and inflammatory diseases. A rich variety of pro-and antiangiogenic molecules …

Vascular Endothelial Growth Factor (VEGF) is an endothelial cell-specific mitogen in vitro
and an angiogenic inducer in a variety of in vivo models. The tyrosine kinases Flt-1 and KDR …

Vascular endothelial growth factor (VEGF, VEGF-A) is a major regulator of physiological and
pathological angiogenesis. Several VEGF inhibitors have been approved by the FDA for the …

Vascular endothelial growth factor (VEGF) is a fundamental regulator of normal and
abnormal angiogenesis. Recent evidence indicates that VEGF is essential for embryonic …

Since the discovery of vascular endothelial growth factor (VEGF), therapeutic angiogenesis
has attracted interest as an alternative treatment for ischaemic heart and peripheral disease …